Abstract:Background Tuberculosis (TB) remains a major public health concern worldwide. Previous studies have demonstrated that IL-17 plays an important role in initial immune response and is involved in both immune-mediated protection and pathology following infection with Mycobacterium tuberculosis (MTB). However, the alterations and regulation of plasma IL-17 level during TB treatment remain unclear. Moreover, the cell type responsible for the production of IL-17 in TB patients requires further study. Methods A total of 20 acid-fast bacilli smear-positive (AFB-positive) pulmonary TB patients and 20 age- and gender-matched healthy volunteers were included in our study. Blood samples were collected in heparinized tubes at the time of diagnosis (AFB-positive group) and 3 weeks after the initiation of therapy, when the sputum smear conversion (AFB-negative group) occurred, followed by symptomatic improvement. IL-17 levels and IL-17-producing cells in PBMCs were detected. Lymphocyte populations in the peripheral blood between the AFB-positive and AFB-negative groups were compared by flow-cytometry. A549 cells, a cell line of alveolar epithelial cells, were applied to determine the extent of the pathological damage mediated by IL-17 following MTB infection. Recombinant human IL-10 was used to investigate the regulation of IL-17 expression after sputum smear conversion in AFB-positive pulmonary TB patients. Results Plasma IL-17 level were elevated in patients with sputum AFB-positive pulmonary TB, but substantially decreased after TB treatment and smear conversion. Our data indicate that NKT-like cells might be the main source of IL-17, in addition to conventional T cells in AFB-positive pulmonary TB patients. The secretion of IL-17 may be suppressed by regulatory T (Treg) cells and IL-10 during TB treatment. Moreover, the IL-17 levels were positively correlated to both the C-reactive protein and erythrocyte sedimentation rate. Therefore, IL-17 was capable of alveolar epithelial cell damage following MTB infection. Conclusion The increase in the frequency of Treg cells and IL-10 levels was associated with a decrease in IL-17 in patients receiving TB treatment. Thus, IL-10 and Tregs may function to inhibit immune-mediated pathology in TB patients.

Pleural Fluid from Tuberculous Pleurisy Inhibits the Functions of T Cells and the Differentiation of Th1 Cells Via Immunosuppressive Factors

Imbalance of Th17 Cells and Regulatory T Cells in Tuberculous Pleural Effusion.

Biological functions of Mycobacterium tuberculosis-specific CD4+T cells were impaired by tuberculosis pleural fluid

CD39+ Regulatory T Cells Suppress Generation and Differentiation of Th17 Cells in Human Malignant Pleural Effusion Via a LAP-dependent Mechanism

The immune characterization of interferon-β responses in tuberculosis patients

Differentiation and Recruitment of IL-22-producing Helper T Cells Stimulated by Pleural Mesothelial Cells in Tuberculous Pleurisy.

The regulation and potential role of interleukin-32 in tuberculous pleural effusion

ESAT‐6‐ and CFP‐10‐Specific Th1, Th22 and Th17 Cells in Tuberculous Pleurisy May Contribute to the Local Immune Response Against Mycobacterium Tuberculosis Infection

Decreased IL-17 during treatment of sputum smear-positive pulmonary tuberculosis due to increased regulatory T cells and IL-10

Increased Frequencies of T Helper Type 17 Cells in Tuberculous Pleural Effusion.

Pleural Fluid Mononuclear Cells (pfmcs) from Tuberculous Pleurisy Can Migrate in Vitro in Response to CXCL10

B lymphocytes that migrate to tuberculous pleural fluid via the SDF-1/CXCR4 axis actively respond to antigens specific for Mycobacterium tuberculosis.

The changes and its significance of Th17 and Treg cells and related cytokines in patients with tuberculosis pleurisy

Increased Soluble and Membrane-Bound Pd-L1 Contributes to Immune Regulation and Disease Progression in Patients with Tuberculous Pleural Effusion

Different Subsets of Macrophages in Patients with New Onset Tuberculous Pleural Effusion

Tuberculous Pleurisy Drives Marked Effector Responses of Γδ, CD4+, and CD8+ T Cell Subpopulations in Humans.

Predominance of Th1 Immune Response in Pleural Effusion of Patients with Tuberculosis among Other Exudative Etiologies

Modulatory effect of Tim-3/Galectin-9 axis on T-cell-mediated immunity in pulmonary tuberculosis

T-Lymphocytes Immune Function of IFN-Gamma Production from Tuberculous Pleural Effusions Assayed by ELISPOT

High Il-35 Pleural Expression In Patients With Tuberculous Pleural Effusion

Immune Responses and Immigration of Mycobacterium Tuberculosis-Specific T Lymphocytes in Patients with Tuberculous Pleuritis